Quantitative Myocardial Cytokine Expression and Activation of the Apoptotic Pathway in Patients Who Require Left Ventricular Assist Devices

Background—Molecular mechanisms underlying the deterioration of patients undergoing LV assist device (LVAD) implantation remain poorly understood. We studied the cytokines tumor necrosis factor (TNF)-&agr; and interleukin (IL)-1&bgr; and IL-6 and the terminal stage of the apoptotic pathway in patients with decompensating heart failure who required LVAD support and compared them with patients with less severe heart failure undergoing elective heart transplantation. Methods and Results—Myocardial and serum samples from 23 patients undergoing LVAD implantation were compared with those from 36 patients undergoing elective heart transplantation. Myocardial TNF-&agr; mRNA (1.71-fold;P <0.05) and protein (3.43±0.19 versus 2.95±0.10 pg/mg protein;P <0.05) were elevated in the LVAD patients. Immunocytochemistry demonstrated TNF expression in the myocytes. Serum TNF-&agr; was also elevated (12.5±1.9 versus 4.0±0.4 pg/mL;P <0.0001) in the LVAD patients. IL-6 mRNA (2.57-fold higher;P <0.005) and protein (27.83±9.35 versus 4.26±1.24 pg/mg protein;P <0.001) were higher in the LVAD candidates, as was serum IL-6 (79.3±23.6 versus 7.1±1.6 pg/mL;P <0.0001). Interleukin-1&bgr; mRNA expression was 9.78-fold higher in the LVAD patients (P <0.001). iNOS mRNA expression was similar to that in advanced heart failure patients and was not further elevated in the LVAD patients. Levels of procaspase-9 (8.02±0.91 versus 6.16±0.43 oligodeoxynucleotide [OD] units;P <0.01), cleaved caspase-9 (10.02±1.0 versus 7.34±0.40 OD units;P <0.05), intact and spliced DFF-45 (4.58±0.75 versus 2.84±0.23 OD units;P <0.05) were raised in LVAD patients, but caspase-3 and human nuclease CPAN were not. Conclusions—Elevated TNF-&agr;, IL-1&bgr;, and IL-6 and alterations in the apoptotic pathway were found in the myocardium and elevated TNF-&agr; and IL-6 in serum of deteriorating patients who required LVAD support. These occurrences may have therapeutic implications and influence the timing of LVAD insertion.

[1]  R. Hawley,et al.  Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. , 1995, Cancer Research.

[2]  R. Virmani,et al.  Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Moncada,et al.  The role of nitric oxide in cardiac depression induced by interleukin‐1β and tumour necrosis factor‐α , 1995 .

[4]  S. Moncada,et al.  The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. , 1995, British journal of pharmacology.

[5]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[6]  R. Holubkov,et al.  Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  H. Robenek,et al.  Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. , 1998, The Thoracic and cardiovascular surgeon.

[8]  M. Yacoub,et al.  Elevated Tumor Necrosis Factor-&agr; and Interleukin-6 in Myocardium and Serum of Malfunctioning Donor Hearts , 2000, Circulation.

[9]  A. Roulston,et al.  CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45 , 1998, Current Biology.

[10]  M. Yacoub,et al.  Upregulation of the Bcl-2 family of proteins in end stage heart failure. , 2000, Journal of the American College of Cardiology.

[11]  J. Lommi,et al.  Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. , 1997, European heart journal.

[12]  K. Webster,et al.  Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. , 1999, Circulation research.

[13]  J. Hosenpud,et al.  Interleukin-1-induced myocardial depression in an isolated beating heart preparation. , 1989, The Journal of heart transplantation.

[14]  D. Mann,et al.  Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.

[15]  T. Kishimoto,et al.  Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Zechner,et al.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.

[17]  M. Yacoub,et al.  The role of nitric oxide and cytokines in heart failure. , 1997, Coronary artery disease.

[18]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[19]  D. Fukai,et al.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[20]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[21]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[22]  M. Yacoub,et al.  Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy , 1996, The Lancet.

[23]  V. Kidd,et al.  Cleavage of DFF-45/ICAD by Multiple Caspases Is Essential for Its Function during Apoptosis* , 1998, The Journal of Biological Chemistry.

[24]  D. Mann,et al.  Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. , 1995, The Journal of clinical investigation.

[25]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.